UBS O'Connor’s Colgate-Palmolive CL Stock Holding History

UBS O'Connor’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-100,000	Closed	-$31K	–	413
2013 Q3	$31K	Buy	+100,000	New	+$5.92M	﹤0.01%	397

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS O'Connor's CL Position: Q1 2018 in Review

UBS O'Connor sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 272,147 shares — an estimated $20.5M sold.

UBS O'Connor first reported a position in CL in Q3 2013 and held it in 9 quarters. The position peaked at $59.4M in Q3 2013. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

UBS O'Connor reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
UBS O'Connor sold 272,147 Colgate-Palmolive shares in Q1 2018, an estimated $20.5M.
UBS O'Connor first reported a position in Colgate-Palmolive in Q3 2013 and held it in 9 quarters.
UBS O'Connor's Colgate-Palmolive position peaked at $59.4M in Q3 2013.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on UBS O'Connor's 13F filing for Q1 2018, filed 14 May 2018.